GlassScriptPhysician profile
Ashleigh Clark
NPI 1457749947
$1,277.13
in general payments reported to CMS, 2019-2025
15 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.86 · 2022: $263 · 2023: $383 · 2024: $231 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897 · Education: $95.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.70 |
| Education | $95.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $270.81 | 2022-2025 | |
| Astellas Pharma US INC | $251.24 | 2023 | Veozah, Myrbetriq |
| Biogen, INC. | $230.75 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $139.12 | 2021-2023 | |
| Hologic Sales and Service, LLC | $78.02 | 2022-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Sumitomo Pharma America, INC. | $69.55 | 2023-2025 | Myfembree |
| Optumhealth Care Solutions, LLC | $44.22 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Millicent US INC | $41.79 | 2024-2025 | Femlyv, Intrarosa |
| Ethicon US, LLC | $36.77 | 2022 | |
| Myovant Sciences INC. | $28.83 | 2022 | |
| Solventum Corporation | $20.69 | 2025 | Prevena |
| Therapeuticsmd, INC. | $20.03 | 2022 | |
| Merck Sharp & Dohme LLC | $19.34 | 2025 | Gardasil 9 |
| Exeltis, USA INC. | $16.39 | 2022 | |
| Channel Medsystems, INC. | $9.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashleigh Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.